Breast Cancer and Levonorgestrel-Releasing Intrauterine Systems

Women with a BRCA-1 mutation carry a risk of up to 72% of developing breast cancer during their lifetime and an increased risk of up to 44% of developing ovarian cancer • How are carriers detected and what are the solutions available? - This is what Dana Grotsky's journey looks like

International group publishes first clinical guidance on polygenic risk scores for breast cancer

Experts release first clinical guidance on polygenic risk scores for breast cancer, outlining integration into screening and prevention strategies.

Breast Cancer and Levonorgestrel-Releasing Intrauterine Systems

To the Editor A recent Research Letter from Denmark explored the growing evidence of the link between the increased risk of breast cancer and levonorgestrel-releasing intrauterine systems (LNG-IUSs), joining studies from the UK and Sweden.